Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius M M, Loff S, Back W, Kaufmann A, Keller K-M, Blaas S H, Siebert R, Vogt S, Spranger S, Holinski-Feder E, Sunde L, Propping P, Friedl W
Institute of Human Genetics, University of Bonn, Wilhelmstrasse 31, D-53111 Bonn, Germany.
J Med Genet. 2007 Nov;44(11):702-9. doi: 10.1136/jmg.2007.052506. Epub 2007 Sep 14.
In patients with juvenile polyposis syndrome (JPS) the frequency of large genomic deletions in the SMAD4 and BMPR1A genes was unknown.
Mutation and phenotype analysis was used in 80 unrelated patients of whom 65 met the clinical criteria for JPS (typical JPS) and 15 were suspected to have JPS.
By direct sequencing of the two genes, point mutations were identified in 30 patients (46% of typical JPS). Using MLPA, large genomic deletions were found in 14% of all patients with typical JPS (six deletions in SMAD4 and three deletions in BMPR1A). Mutation analysis of the PTEN gene in the remaining 41 mutation negative cases uncovered a point mutation in two patients (5%). SMAD4 mutation carriers had a significantly higher frequency of gastric polyposis (73%) than did patients with BMPR1A mutations (8%) (p<0.001); all seven cases of gastric cancer occurred in families with SMAD4 mutations. SMAD4 mutation carriers with gastric polyps were significantly older at gastroscopy than those without (p<0.001). In 22% of the 23 unrelated SMAD4 mutation carriers, hereditary hemorrhagic telangiectasia (HHT) was also diagnosed clinically. The documented histologic findings encompassed a wide distribution of different polyp types, comparable with that described in hereditary mixed polyposis syndromes (HMPS).
Screening for large deletions raised the mutation detection rate to 60% in the 65 patients with typical JPS. A strong genotype-phenotype correlation for gastric polyposis, gastric cancer, and HHT was identified, which should have implications for counselling and surveillance. Histopathological results in hamartomatous polyposis syndromes must be critically interpreted.
在青少年息肉病综合征(JPS)患者中,SMAD4和BMPR1A基因大片段基因组缺失的频率尚不清楚。
对80例无亲缘关系的患者进行了突变和表型分析,其中65例符合JPS临床标准(典型JPS),15例疑似患有JPS。
通过对这两个基因进行直接测序,在30例患者中鉴定出点突变(占典型JPS患者的46%)。使用多重连接依赖探针扩增(MLPA)技术,在所有典型JPS患者中,14%发现了大片段基因组缺失(SMAD4基因中有6处缺失,BMPR1A基因中有3处缺失)。对其余41例突变阴性病例的PTEN基因进行突变分析,发现2例患者存在点突变(5%)。SMAD4突变携带者胃息肉的发生率(73%)显著高于BMPR1A突变患者(8%)(p<0.001);所有7例胃癌均发生在携带SMAD4突变的家族中。有胃息肉的SMAD4突变携带者在胃镜检查时的年龄显著大于无胃息肉者(p<0.001)。在23例无亲缘关系的SMAD4突变携带者中,22%临床诊断为遗传性出血性毛细血管扩张症(HHT)。记录的组织学发现包括多种不同类型息肉的广泛分布,与遗传性混合息肉病综合征(HMPS)中描述的情况相当。
对65例典型JPS患者进行大片段缺失筛查后,突变检出率提高到了60%。发现胃息肉、胃癌和HHT存在强基因型-表型相关性,这对咨询和监测具有重要意义。对错构瘤性息肉病综合征的组织病理学结果必须进行严格解读。